Abstract
INTRODUCTION
The current international drug control system was built under the auspices of the United Nations, and is centred institutionally in Vienna. Vienna is the location for the annual convening of the UN's Commission on Narcotic Drugs (CND), the UN's principal specialist policy organ on drug control, and for the sessions of the International Narcotics Control Board (INCB), the expert technical committee which monitors global drug control. It is also the home of the UN Office on Drugs and Crime (UNODC), which provides administrative facilitation for the system. 1 At the heart of the system is apparent consensus about drug prohibition except for medical and scientific purposes. Expressed through the provisions of the drug conventions, it is reflected institutionally in the usually consensus based decision making processes within the CND. 2 This support for a single position on drug control stands in stark contrast to the highly conflictual situation that developed within the League of Nations international drug control fora in the pre-War period. The commodity control agreements 3 which formed the basis of League control had been under significant stress in the period up to 1941 because of controversy over regulated drug markets in territories in Asia under colonial control producing surpluses that fed into, in particular, demand in the United States. 4 The League's drug control system foundered Provisions safeguarding State party discretion in implementation are, for example, common. 15 Recently, however, more challenging notes of dissonance have begun to be heard from States. Given the existence of these tensions and the upcoming United Nations General Assembly Special Session on drugs in 2016 which provides an official opportunity for some reassessment of the system of international drug control by States, 16 it is timely to ask whether, and if so why, States have begun 'Waltzing on Vienna'.
There are many areas of policy tension within the evolving global drug control system, but only a few have led to reference to the provisions of the drug conventions and to claims of transgression of the objectives of the system. This piece begins in part 2 by examining a clear signifier of tension in the system: renewed interest in the object and purpose of the system. With a view to a general comment on their systemic and broader impacts, part 3 briefly examines a number of these topical areas of tension within the global illicit drug control system, summarising the policy battles and their effect on the legal rules. The areas examined (in rough chronological in order to give some sense of the historical growth of discord in the system) are State flexibility on personal use, harm reduction, human rights issues, Bolivia's denunciation and re-ratification with reservation in regard to coca leaves, and the introduction of legal use and legal markets for cannabis within certain States. Part 4 then engages in an assessment of the general systemic impact of the system of these tensions.
THE OBJECT AND PURPOSE OF THE INTERNATIONAL DRUG CONTROL SYSTEM
The objectives of the international drug control system took some time to settle. As noted above, the League period saw a struggle between States like Britain, which sought only official control of supply but without limitation of use, and the United States, which sought limitation of supply only for these exclusive uses, a struggle won by the United States. Following Vienna Convention 17 orthodoxies a textual analysis of the current drug conventions reveals that their common objectives are to specifically limit 'the production, manufacture, export, import, distribution of, trade in, use and possession of' the drugs scheduled under the treaties 'to medical and scientific purposes' 18 and to 'suppress' other illicit activities. 19 These objectives are entwined; the principle that certain activities are to be exclusively lawful dictates that other activities are not and those are the activities to be suppressed. At the Diplomatic Conference that settled the 1961 Single Convention, the British Representative, Mr. Green, the first speaker at the negotiations, noted 4 that narcotics control had two aspects: The limitation of production to legitimate purposes and the prevention of the illicit traffic. The object was to eliminate abuses without hindering the use of narcotics for therapeutic purposes or impeding scientific progress. 20 The preamble of the 1961 Single Convention reminds us that it is designed to provide for 'continuous international co-operation and control for the achievement of such aims and objectives'. 21 The system thus requires sustained adherence to these objectives of limitation and elimination. While the drug conventions do permit discretion to States parties in certain areas such as treatment of users they do no permit the same degree of latitude in regard to control of the supply of drugs.
Until recently most States parties have concentrated upon suppression as a technical problem and there has been little interest in exploring the drug control system's ultimate purposes. Recent pressure for change exerted by civil society has refocused attention on the system's purpose. Lines, drawing on the preambles of the drug conventions, notes that this purpose is to attain its objectives for the benefit of the 'health and welfare of mankind', 22 and this view is shared by the UN General Assembly in 2014. 23 Whether the objectives of limitation to medical and scientific purpose and suppression of the illicit activities have or ever will achieve the health and welfare of mankind is, however, increasingly disputed. 24 Critics argue that the system operates on the undemonstrated assumption that suppressing supply and demand will achieve positive health and welfare outcomes and that even on its own terms it has failed to suppress these activities. 25 The following areas of tension in the international drug control system serve as focal points for this kind of criticism.
AREAS OF TENSION IN THE INTERNATIONAL DRUG CONTROL SYSTEM

Flexibility on Personal Use
Signs of a more flexible position being taken by States in regard to the objective of elimination of abuse of proscribed drugs first appeared in the modulation of their approaches to personal use offences. The UN Drug Conventions do not oblige States parties to criminalise use per se; instead possession for personal use functions as a proxy offence to achieve this purpose. However, even here, as a result of the lack of consensus about using criminalization the text contains a safeguard clause subjecting the obligation to the 'constitutional principles and the basic principles of [the party's] legal system'. If these options for not criminalising are not available, the express terms 'to establish as a criminal offence' present a clear obligation. The UN's Commentary on the 1988 Convention, however, recognises that the provisions for treatment and rehabilitation in article 3(4)(d) as an alternative to punishment affords States parties some latitude in regard to how to execute the obligation in article 3(2).
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In the 1960s and 1970s states within the United States were the first to begin to reduce the penalties for cannabis use, then began stopping prosecuting cannabis personal use offences as a matter of policy, and finally decriminalised entirely. 29 In Europe, the Netherlands decriminalised personal use in 1976. 30 In the late 1980s states in Australia began to decriminalise by applying administrative penalties. 31 The causes of relaxation varied from the negative human rights implications of criminalisation to more prudential use of public and in particular law enforcement resources.
These modulations have not usually constituted direct challenges to the objectives of the drug conventions. Spain (1992) 32 and Italy (1990), 33 for example, adopted a system of administrative penalties for possession of all drugs which arguably conform to the conventions. 35 The International Narcotics Control Board (INCB), which took upon itself the task of maintaining the integrity of the system, was quick to 'remind' States of their obligation under article 3(2) of the 1988 Convention. 36 State practice like Portugal's, however, indicated increasing use of the inbuilt capacity for flexible interpretation of article 3(2)'s obligation 'to establish as a criminal offence', if only in limited cases. In 2004 the INCB conceded that 'the practice of exempting small quantities of drugs from criminal prosecution is consistent with the international drug control treaties', but continued to emphasise that the objectives of the conventions were to limit abuse. 37 In 2009, utilising the safeguard clause to article 3(2), Mexico passed a law providing that possession of small amounts of heroin, opium, cannabis and cocaine would no longer lead to criminal prosecution. 38 The INCB in 2009 in its Annual Report reminded Mexico of its article 3(2) obligations, 39 but Mexico has not changed its practice. The aforementioned examples illustrate legislative/executive use of the safeguard clause but the domestic courts have also used this clause. In 2009 the Argentine Supreme Court declared criminalisation of possession for personal consumption in private places a constitutional breach because it interferes with the right to personal autonomy. 40 Faced with this wave of reforms in regard to personal use in 2009 the INCB responded generally that it was concerned about political support for the movement to decriminalize possession among high profile politicians and noted that the movement posed a 'threat to the coherence and effectiveness' of the system, sent the 'wrong message to the general public', and unless 'resolutely countered' would undermine drug control. 
Harm Reduction
Harm reduction measures such as drug maintenance and substitution programmes, needle and syringe exchanges, drug consumption rooms, and so forth, present another challenge to the system. 42 While they are designed to reduce attendant harm of use such as infection, they have been characterised by antagonists inter alia as aiding and abetting in the abuse of drugs. 43 Their legality can be defended through reference to the narrow interpretive scope 44 that flows from the absence of a constraining definition of 'medical and scientific purposes' and provision in the conventions for States parties at their discretion to offer measures of treatment, education, aftercare, rehabilitation, and social integration as alternatives or additions to criminal penalties. 45 Under the UN Political Declaration on the Guiding Principles of Demand Reduction Control adopted at the 1998 UN General Assembly Special Session on the World Drug Problem, States committed to offer 'the full spectrum of services, including reducing the adverse health and social consequences of drug abuse for the individual and for the society as a whole ' . 46 Yet the UN's drug control organs in Vienna and in particular the CND have been the forum for an ongoing political rather than legal conflict about the use of 'harm reduction', placing them out of step with other UN organisations involved with public health where its use is commonplace. 47 In 2002 the UNDCP legal section opined that there was sufficient flexibility in the drug conventions to accommodate harm reduction. 48 Yet the term is not used at all, for example, in the 2014 report of the INCB. 49 The conflict over the legality of drug injection rooms provides a concrete example of the harm reduction debate. These safe facilities for drug use are provided lawfully in Australia, Canada, Germany, Switzerland, the Netherlands, Luxembourg, Spain and Norway. In spite of recognition by the WHO of 'compelling evidence' that they reduce HIV infections in a cost effective manner, 50 in 2000 the INCB noted that establishing drug injection rooms 'is contrary to the international drug control treaties' 51 and in 2004 stated 'they are against the central principle embodied in the drug control treaties, namely that the use of drugs should be limited to medical and scientific purposes only.' 52 Proponents argued that these rooms are lawful so long as they did not permit sale, acquisition or passing on of drugs, are genuinely risk reducing, and subject to adequate control. 53 They noted that the drug conventions are silent on whether these rooms constitute a legitimate practice of social reintegration and rehabilitation, that state practice is unclear, and therefore argued the matter is for States parties. 57 The INCB responded in 2011 that 'the provisions of internal law cannot be invoked to justify non-compliance with provisions of the international drug control treaties to which a State has become a party'. 58 However, by 2014 it had ameliorated its position, simply reiterating 'its concern that such facilities could be inconsistent with the provisions of the international drug conventions.' 59 The INCB's position only indicates that it thinks that the system is threatened by harm reduction; it does not speak for all States parties in this regard. There is probably sufficient flexibility within the system to accommodate harm reduction because as it is aimed at amelioration of conditions affecting the health and welfare of users of drugs it does not constitute a direct challenge to the central provisions in the conventions that limit the supply of drugs to medical and scientific purposes.
Human Rights Problems
In addition to harm reduction failures, the human rights failures of the international drug control system are legion. The object of limitation limits access of the vast majority of people to moderate or severe pain relief and more generally restricts access to medicines because of potential diversion to the illicit trade. The object of elimination impacts disproportionately on black people in North America and Europe, drug-crop eradication produces collateral costs to health and the local economy in agricultural drug-producing States, and the use of large-scale violence in operations against drug cartels, police brutality against individual suspects in custody, detention without trial for the purpose of treatment of drug users, and the employment of the death penalty against drug traffickers all have negative human rights impacts. 60 These shortcomings result from the negligible reference to human rights in the development and administration of the drug conventions, 61 the result of an absence of consensus at the time on either inclusion of human rights control or a human rights mandate to the drug control bodies. Recent rhetorical commitment to carrying out the commitments in the conventions 'in full conformity' with international human rights instruments is usually finely balanced with reference to state sovereignty and the principle of non-intervention. 62 It is a matter of concern, however, that the drugs conventions and the drug control institutions have an indirect but influential relationship with human rights abuses; while they do not prescribe them, they do structure the system that employs them at a national level. This relationship of influence is well illustrated by the controversy that surrounds the application of the death penalty to drug supply convictions. As the UN Special Rapporteur on the Right to Health, Anand Grover has recorded, 32 jurisdictions currently apply capital punishment to drug offences, some mandatorily. 63 Convention. The Court considered that the imposition of death was appropriate because the Indonesian drug trafficking offences implementing the 1988 Convention was a valid exception to the prohibition on interference with the right to life in article 6 of the ICCPR under paragraph (2), which did not prohibit the imposition of the death penalty for the 'most serious' crimes. Rejecting the opinion of the UN Human Rights Committee that drug trafficking offences were not among the 'most serious crimes', 67 the Court considered there to be no substantial difference between them and 'most serious crimes' like genocide because they also affected the 'economic, cultural and political foundations of society' and carried 'danger of incalculable gravity'. 68 There is little analogous content between core international crimes involving proof of intentional killing and injury, and drug supply offences resting on a presumption of intent to traffic based on volume of the drug carried. Drug supply covers a wide range of conduct from the trivial to the serious, something recognised by the Convention itself through the application of aggravating factors that are by definition not present in every case. 69 The Indonesian position continues to cause serious tensions with States whose nationals are executed for committing this offence. 70 The UNODC Executive Director has noted that the weight of opinion is that these offences do not reach the threshold of most serious crimes and has advocated its abolition. 71 The INCB has also moved on this issue, and now encourages States 'to consider 64 The Vienna consensus is considered a hurdle to progress on human rights because it mutes criticism of State practices that violate human rights. 74 It stands in marked contrast to the strong mutual criticism of State practices by participants in debates within the League's Opium Advisory Committee. 75 That criticism was, however, directed at failures to enforce limitation, not at violation of rights through limitation or enforcement.
Bolivia's Repudiation and Re-ratification with a Reservation of the 1961 Convention
The 1961 Single Convention is in part a response to concerns in the developed world that its problems with the non-medical use of narcotics are fuelled by the traditional cultivation of the plants from which these drugs are derived. 76 Coca leaf chewing is endemic in Bolivia both as a cultural practice of indigenous people and as a relief for altitude sickness. 77 There is a conflict between the cultural right of indigenous peoples to enjoy this cultural custom and the obligations under the 1961 Convention. 78 In terms of article 2(6) coca leaf is subject to all the measures of control in the convention, as well as to specific measures in articles 26 (regulation of cultivation through a national agency and taking possession of crop) and 27 (cultivation for use as a flavouring agent). In terms of article 49(1) a State party could make a temporary reservation in regard to the chewing of coca leaves but in terms of article 49(2)(e) coca leaf chewing had to be abolished within 25 years of the Convention coming into force. It came into force in 1964 and therefore the obligation to abolish coca leaf chewing became absolute in 1989 for those States parties that made the reservation; for other non-reserving State parties coca leaf was subject to control in 1964.
Bolivia, a party since acceding on 23 September 1976, had not made such a reservation and was thus under the obligation to implement control of coca leaf from accession but had never actually implemented this prohibition, maintaining the legality of the practice under its domestic law, 79 a fact commented on by the INCB. 80 Bolivia attempted to formalise its position of non-implementation after adopting a new constitution in 2009 that recognised 'the rights of indigenous peoples to their cultural identity, spirituality, practices and customs' 81 and protected coca in its natural state as 'cultural patrimony'. 82 Citing this conflict with indigenous peoples' rights (by implication with the provisions of the convention) and arguing there was no conflict with the health objects and purposes of the Convention in doing so, Bolivia sought to change The Convention provides in article 47 that if a proposed amendment has not been rejected by any party within an 18 month it automatically comes into force; if there are objections ECOSOC must decide if a conference of the parties is necessary to consider the amendment. Twenty one States parties did raise objections to the proposal, while only 18 mainly Latin American States supported it. 84 The United States, for example, objected as follows:
Through ratification of the Single Convention, member states undertake an obligation to limit the trade and use of drugs exclusively to medical and scientific purposes. Member states also recognise measures against the abuse of narcotic drugs require coordinated and universal action. Schedule I to the Single Convention lists coca leaf as a narcotic drug. In considering the proposed amendment, Member States must remain guided by the principles and objectives of the Single Convention. In accordance with Article 47, paragraph 1(b), of the Single Convention, the mission informs the United Nations that the United States of America, consistent with its general obligations outlined in Article 4 of the Convention, does not accept the proposed amendment.
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Ironically it is questionable whether amendment of article 49 would have achieved Bolivia's goal as coca leaf would have remained in Schedule 1 and subject to all the provisions in the Convention. However, the objections halted further progress and Bolivia did not wait for ECOSOC to decide whether a conference was necessary to clarify matters. It switched tactics and denounced the Convention on 29 June 2011 by notification to the UN Secretary General, with its withdrawal taking effect from 1 January 2012. 86 It then re-acceded but with the following reservation:
The Plurinational State of Bolivia reserves the rights to allow in its territory: traditional coca leaf chewing; the consumption and use of the coca leaf in its natural state of cultural and medicinal purposes, such as its use in infusions; and also the cultivation, trade and the possession of the coca leaf to the extent necessary for these licit purposes. At the same time, the Plurinational State of Bolivia will continue to take all necessary measures to prevent its abuse and the illicit production of narcotic drugs which may be extracted from the leaf. 87 Under article 19 of the Vienna Convention on the Law of Treaties, a reservation must not be 'incompatible with the object and purpose of the treaty.' The legal arguments marshalled for acceptance of Bolivia's withdrawal, re-accession and reservation include allowing a State like Bolivia with specific objections to a particular provision to remain in the system of control, while simultaneously conveying the intensity of its objection to the other parties. 88 The authors of the 1961 Commentary considered a strategy of this kind entirely legal under article 50(3) of the Single Convention, which permits other reservations, stating that 'a party may reserve the right to permit the non-medical uses as provided in article 49, paragraph 1, of the drugs mentioned therein, but also non-medical use of other drugs, without being subject to time limits provided for in article 49.' 89 However, article 50(3) provides that if one third or more States parties (which put the threshold for Bolivia at 61) objected within one year, the strategy would be defeated. By the end of the period only 15 States parties had objected, a weight of objection insufficient to meet the threshold to block the measure. The objecting States parties as Pfeiffer notes were mainly concerned about 'the legal implications of the reservation for the international drug control regime and for the international law of treaties more generally.' 90 Japan objected that the reservation 'seems to be in conflict with the object and purpose of the 1961 Convention to prevent the illicit production, manufacture and trafficking of cocaine'. 91 Russia worried that '[t]his step also establish a dangerous precedent and might be used by other states in order to establish in their territories more liberal drug control machines that are provided for by the' drug conventions. 92 Sweden 'had serious concerns regarding the procedure' followed by Bolivia noting that '[s]uch practice would constitute a misuse of the procedure and would undermine the basis of international treaty and the International legal framework for the fight against drugs.' 93 The INCB noted Bolivia' step with regret and continued:
The Board is concerned that, while that course of action is technically permitted under the Convention, it is contrary to the fundamental object and spirit of the Convention. If the international community were to adopt an approach whereby States parties would use the mechanism of denunciation and re-accession with reservations to overcome problems in the implementation of certain treaty provisions, the integrity of the international drug control system would be undermined.
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Bolivia's re-accession came into force on the 10 February 2013.
The impact of this process on the general international law of treaties is beyond the scope of this article. However, in the context of international drug control the implication is that the system yielded when pushed hard in novel ways on a single issue. Bolivia had not pursued a process of the interpretation of the conflicting legal obligations but instead forced the drug control obligations to give way not for medical but sociocultural reasons. 95 The ending of exceptions for the cultivation of specific narcotic producing plants was considered 96 Unsurprisingly this 'reform by subtraction' has been touted as useful as a tool for wider reform of the system. 97 From a voluntarist point of view Bolivia's action seem entirely permissible within public international law; its utility as a tool for general reform of the system would require wholesale engagement in similar actions by other States parties, a clumsy and for that reason unlikely prospect. Of more immediate practical import however, is that a measure considered symbolically important in the chain of illicit supply has been rolled back by one State party.
The (Re)Introduction of Legal Cannabis Production and Use in Certain States Parties
The harmfulness of cannabis, coupled with widespread use and enforcement action against that use, has made it something of stalking horse for both the proponents and antagonists of reform of the drug control system. States began to test the system when, as described above, they decriminalised personal use offences. The establishment of what is effectively legal use and supply of cannabis for non-medicinal personal consumption has ratcheted up the challenge to the limitation and elimination objectives of the international drug control system.
The Netherlands has led the way in this regard with its 'coffee shop' system. It claims adherence to article 36(1) of the 1961 Convention and article 3 of the 1988 Convention through its Opium Act, 98 justifying its inaction in prosecutorial guidelines 99 that rely on the principle of expediency, which gives the prosecution the discretion not to prosecute if it is in the public interest. The prosecution of offences involving retail sale of up to 5gm to individual customers and the storage of 500gm for this purpose has been given the 'lowest judicial priority'. 100 The Netherlands considers the expediency principle's application in this context to be one of its 'basic legal concepts' protected in the proviso to article 3(2) of the 1988 Convention. The difficulty is the supply of cannabis through the 'back door' into the coffee shops. Legal tolerance of quantities for commercial trading by the shops themselves is not subject to article 3(2)'s proviso but falls under the unqualified obligation under article 3(1). Article 3(6) of the 1988 Convention obliges the States parties to 'endeavour' to ensure that 'discretionary legal powers' are 'exercised to maximize the effectiveness of law enforcement measures'. The Netherlands, however, made a reservation to article 3(6) that it accepted it only to the extent that it accorded with 'Dutch criminal legislation and Dutch policy on criminal matters.' 101 The INCB has repeatedly condemned this system 102 but in its latest report was silent, as the Dutch have been joined by other more extravagant dissenters.
Although it had long ceased to penalize possession of small amounts of drugs including cannabis, in 2014 Uruguay legislated to permit the cultivation of up to six cannabis plants as well as the formation and registration of cannabis growing clubs. 103 to a step which echoes the State controlled monopolies of the League era: Uruguay institutionalised State control of the chain of supply of the drug through the Institute for Regulation and Control of Cannabis, permitting individuals of 18 years and older to buy up to 40 grams of cannabis from this state monopoly per month. Uruguay acknowledges that there its position is contentious and acknowledges that the drug control conventions may require revision and modernisation, but defends its position by referring to human rights protections and by claiming that its policies accord with the original purposes of the drug control treaties, protection of the health and welfare of mankind.
104 State controlled sale is yet to take place, but private growing has gone ahead.
Perhaps the most interesting defection, or more kindly, realignment of interests, has occurred in the United States, as it comes to terms with the heavy load that policing and punishing trivial drug offences has placed on its criminal justice infrastructure. When Alaska on grounds of protection of privacy decriminalized possession of four ounces of cannabis in state law through decisions of its courts, 105 a tension emerged between legality at the state level and illegality at federal level. This tension ratcheted up when beginning with California in 1996, a number of US states introduced limited exemptions for the supply of cannabis for medical purposes. 106 The US federal authorities had initially continued to prosecute violations by medical cannabis growers of the Controlled Substances Act (CSA) but announced in 2009 that it was adopting a 'Non Enforcement Policy' to the effect it would stop enforcing the federal laws against individuals that comply with state medical marijuana laws. 107 In 2010 the INCB noted that it was ' deeply concerned about [the] " medical" cannabis schemes' that had been introduced in a number of US states and complained that the ' control measures applied in those states to the cultivation of cannabis plants and the production, distribution and use of cannabis fall short of the control requirements of the 1961 Convention'. 108 Its complaint was directed at non-compliance with article 28 of the 1961 Convention, which requires the establishment of a national cannabis agency to which all growers must deliver their crops, if a State party is going to permit the cultivation of cannabis. However, the INCB also felt that the medical utility of cannabis was unproven (a technical classification which the INCB itself is not mandated to make). The INCB applauded the United States Government for stating that it was opposed to the legalization of cannabis and would continue to enforce federal law against cannabis cultivation and supply, which the INCB took as 'confirming the Board's position that federal law supersedes state law with regard to the obligations contained in the international drug control conventions.'
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The INCB was not, however, able to prevent the unfolding of a more significant challenge to the international drug control system originating within the United States. Beginning in 2011, state laws have been enacted permitting state regulation and taxation of the cannabis market initially in Colorado 110 and Washington 111 (although they have since been joined by others). The US federal authorities responded with a 2013 Memorandum from the Justice Department, which reaffirmed that cannabis was a dangerous drug and illegal supply a serious crime. 112 It set enforcement priorities as prevention of sale to minors, the generation of revenue by enterprises, gangs and cartels, diversion to states where it remains illegal, preventing authorised activities from being used as a cover for trafficking in other illegal drugs or illegal activities, violence and the use of firearms in the production of cannabis, drugged driving and other adverse public health consequences, growing on public lands, and growing on federal property. 113 Noting that it had because of resource limitations usually left enforcement activities that did not fall within these priorities to local and state authorities, its expectations are that these authorities will provide 'strong regulatory and enforcement systems that will address the threat that those state laws pose to public safety, public health and other law enforcement interests.' 114 It will only step in and challenge these state laws if state regulation is ineffective and federal enforcement priorities are threatened. 115 It clarifies that large scale or for-profit motive of a cannabis operation can no longer by themselves serve as a proxy for the exercise of prosecutorial discretion. Importantly, the memorandum is subject to the proviso that it serves 'solely as a guide to the exercise of investigative and prosecutorial discretion' and 'does not alter the Department's authority to enforce federal law, including federal laws relating to marijuana, regardless of state law'. 116 The policy does not explicitly approve the creation of cannabis markets within states; it makes it clear that the operation of these markets where they contravene its prosecution priorities will be a Federal priority, but where they do not they will not be a priority. 117 If the reforms work, however, the implication is that cannabis supply will be left unprosecuted in a number of US states, which it has been argued places the United States in contravention of its treaty obligations. 118 The Memorandum itself does not address the United States' obligations under the drug conventions. However, its formal position is that it is not violating these conventions because cultivation, trade and possession of cannabis remain criminal offences under Federal drug law in the form of the CSA. 119 A further leg to this argument appears to be that it believes the treaty provisions permit a 'substantial discretion' regarding where to allocate its law enforcement resources and recognise the limitations placed on compliance by a State party's constitution. 120 The INCB has responded negatively, pointing out that the 1961 Convention limited cannabis to medical and scientific purposes, that the legislation of cannabis in the two states in question 'was not in conformity with the international drug control treaties' and urged 'the Government of the United States to continue to ensure the full implementation of the international drug control treaties on its entire territory.' 121 Does an executive decision not to enforce the law against particular activities (cultivation and supply in its various forms) of a particular drug (cannabis) in a particular place (Washington, Colorado) contravene a party's (the United States) international obligations? Clearly taking action against all contraventions of all drug laws is not required. While confusing as a matter of constitutional law, 122 the United States position does not appear to be legally tenable as a matter of international law. McNair, writing in 1961 noted the general principle:
The division of powers in Federal States between the Federal Government and the Governments of the States or Provinces give rise to special problems. Normally the treaty-making capacity resides in the Federal government, while the legislative power is divided between the Federal government and the Government of the States and Provinces. The principle is clear that if the Federal Government concludes a valid treaty it is responsible for seeing that it is performed. 123 A federal state cannot justify its failure to perform a treaty obligation because of any special features of its constitutional system unless otherwise provided in the treaty itself. 124 The question is whether the drug conventions provide for an exception to the general rule. 125 A candidate is provision for prosecutorial discretion in the conventions. The right to exercise prosecutorial discretion in regard to that criminalisation is recognised in article 36(4) of the 1961 Single Convention (substantially repeated in article 3(11) of the 1988 Convention), which provides that '[n]othing contained in this article shall affect that principle that the offences to which it refers shall be defined, prosecuted and punished in conformity with the domestic law of a Party.' This provision, a savings provision of a kind commonly inserted in penal law treaties, indicates among other things that the execution of enforcement is a matter for the Parties. 126 It is a copy of article 15 of the 1936 Convention for the Suppression of the Illicit Traffic in Dangerous Drugs, 127 which was interpreted at the time of signature as meaning that the parties have a discretion to take into account 'mitigating circumstances'. 128 If nothing else, this implies that discretion is retained but on a case by case basis and the authors of the 1936 Convention did not conceive of it as permitting a blanket decision not to prosecute based on internal law. The United States authorities do enjoy a broad prosecutorial discretion.
129 They may also point the Netherlands reliance on expediency as precedent. It is probably untenable to argue that formal guidance as to discretion is always impermissible, but Krajewski's view that this discretion should be applied with circumspection and only to minor offences or it would otherwise undermine the system is more plausible in the light of the history of pressure on States by other states to make the prohibition system effective. 130 Moreover, it is state law which precedes and which de facto dictates Federal prosecution policy in this case. The United States riposte may be that they it is not exercising its discretion in a blanket fashion but rather it is choosing not to prosecute certain cases due to limited resources made even more limited by the fact that it can no longer rely on state authorities to assist (using the mirror provisions of the CSA contained until recently in state law). The Cole Memorandum explicitly says that if there is a strong federal interest nothing in the policy will prevent prosecution even where none of the priorities are present. 131 Nonetheless, this decision involves a large number of cases in a specific place in regard to a specific substance, some of which may be regarded as serious using the government's own yardstick of quantity of substance supplied; it is far more than the exercise of discretion in a particular case. Furthermore, the discretion argument ignores the fact that the duty to criminalise supply offences under article 3(1) of the 1988 Convention is subject to article 3(6) which obliges them to endeavour to ensure that any discretionary legal powers are used to maximize the effectiveness of law enforcement and with due regard to the need to deter these offences. The current federal policy cannot be said to be an endeavour to deter the sale of cannabis in Colorado and Washington. The Federal authorities may respond that it has enabled the suppression of trafficking in other drugs through reallocation of resources, but they would be more convincing if they were engaging in selective prosecutions within these States of large scale cannabis supply operations.
It also appears untenable to rely on the broader safeguard clauses such as the provision in article 2(1) of the 1988 Convention that States parties must carry out the obligations in the convention 'in conformity with the fundamental provisions of their respective domestic legislative systems' or the more specific provision in article 36(1) of the 1961 Convention that subjects its criminalisation obligation to the party's 'constitutional limitations' justifies a blanket decision not to prosecute in this way. Safeguard clauses of this kind are not blanket get -outs for non-performance of specific obligations unless the domestic law prevents compliance with the particular obligation. As the Canadian delegate who introduced the provisos in article 36(1)(a) and (b) noted, they were included because 'it was useless to impose on countries obligations which they could not meet without changing their legal system'. 132 The US federal authorities are not constitutionally or legally prevented from prosecuting the cultivation and supply of cannabis within Colorado and Washington, they are choosing not to do so as a matter of policy.
The Cole Memorandum de facto if not de jure concedes the existence of a jurisdiction within Colorado and Washington to effectively regulate cannabis markets. Together, the state law and the decision not to prosecute if the state law works can arguably be taken to result in non-compliance with provisions in the drug conventions such as article 4 of the 1961 Convention's unqualified duty 'to limit exclusively to medical and scientific purposes the production, manufacture, export, import, distribution of, trade in, use and possession of drugs'. AS noted, it for the State party to ensure that the Convention applies in all of its federated components. The INCB anticipated this controversy when it stated in 2011:
281. The international drug control treaties must be implemented by States parties, including States with federal structures, regardless of their internal legislation, on their entire territory. While all States have different legal systems and legal traditions, the Board wishes to remind the States parties of the basic principles of international law enshrined in the provisions of articles 27 (on the irrelevance of internal law) and 29 (on the application of the treaty on the entire territory of the party) of the 1969 Vienna Convention on the Law of Treaties.
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The INCB has not asked the United States to explain what provisions of its constitution or domestic law prevent it from complying, although arguably it may do so. 134 Whatismore, the non-prosecution of the banking of the proceeds of the cannabis markets in the states where it has been established almost certainly violates the obligation on the United States to criminalise money laundering in article 3(1)(b) and (c) of the 1988 Convention and in article 6 of the UN Convention against Transnational Organised Crime by both enacting an appropriate law (which has been done) and by enforcing that law.
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The alternative view is that if these acts continue to be established as a criminal offence in the entirety of US territory the drug convention obligations are met, because the safeguard clauses permit such flexibility and they are being interpreted in this way by States parties in their practice without complaint by others (as yet). The US's taking of this view exposes a contradiction between the US's post-war rhetorical commitment to supply control and its own practice. It appears to be intent on sticking with the existing treaties, fostering flexible interpretation to suit changing conditions, tolerating different national strategies and countering transnational criminal networks. 136 In 2014 President Obama said:
The U.N. drug conventions, which recognize that the suppression of international drug trafficking demands urgent attention and the highest priority, allow sovereign nations the flexibility to develop and adapt new policies and programs in keeping with their own national circumstances while retaining their focus on achieving the conventions' aim of ensuring the availability of controlled substances for medical and scientific This leaves the drug control system as a functioning system. Yet there is nothing like a tu quoque accusation to undermine claims by the United States that another State party is breaching its promises. It may be that the US will be accused of undermining the international drug control system by States with growing internal drug use problems of their own who appear to be stronger disciples of the drug war than the originator of this term.
WALTZING, DICORDANCE, OR A NEW TUNE?
The prohibitionist nature of international drug control has been accepted in an uncontested way since drug control fell under UN auspices. Although practice has not been uniform everywhere, a majority of States parties have opted for an at least rhetorical (if not actual) commitment to a predominantly law enforcement approach. This essentially political approach is not always reflected in the nature of the conventions, in particular the 1961 and 1971 conventions, which do permit a degree of flexibility on specific issues of criminalization. However, the political norms that structure international drug control are the production of continuous human effort within the practice of States. When some States through their practice begin to challenge these objectives of the system, they can destabilise what many assume to be immovable. First in regard to use, and more recently in regard to supply, the practice of some States has moved some distance from the objectives of the strict prohibitive position of limitation of the supply and use of drugs to medical and scientific purposes and elimination of others forms of supply and use. It has occasioned repetitive condemnation in the INCB. 138 This condemnation has, however, begun to sound increasingly weary because it is the States parties themselves that guard the Vienna consensus, and that consensus is under pressure.
There are credible arguments that the current system does not meet the overall health and welfare purposes of the conventions. So what does the future hold? One cannot be sanguine about making predictions of major reform of the drug control system; there is too much institutional inertia and too many States have bought heavily into the current approach as the only possible way of controlling their domestic drug problems. On the other hand the major proponent of the current system, the United States, which lost control of the opium question to the League in 1920, regained it in 1946, appears now to be loosening its grip, and of being forced by internal pressure into becoming a reluctant proponent of flexible interpretation. Although rhetorically committed to the drug conventions as frameworks for the effort to suppress the international drug traffic, 139 the US's present ambivalent policy is likely to have an effect on the rigidity of the system as a whole.
One possibility for further change is modification of obligations in respect of certain substances (cannabis is the most likely candidate) amongst like-minded groups of States parties to the conventions, relying on article 41 of the Vienna Convention. 140 Other States parties more committed to absolute prohibition may object to a proposed variation of this kind on the basis of incompatibility with the object and purpose of the drug conventions. If the variation makes it past this hurdle the crunch may come if there is an increased flow of controlled substances from the States Parties that have modified their obligations into other States Parties that have not, giving the latter a material basis for objecting that the modification is affecting their enjoyment of their rights under the treaties or adding to their legal and social burdens. The emerging multispeed drug control system would begin to display friction between its different parts. It would be more principled to align the conventions accurately with the actual criminal laws being enforced against individuals, if only out of respect for the principle of legality. Ideally, States should heed the calls for attempted reform of the system as a whole 141 and regenerate consensus in Vienna, but of a different kind.
